Atypical antipsychotic-induced weight gain
Godlewska, B.R.; Olajossy-Hilkesberger, L.; Marmurowska-Michałowska, H.; Olajossy, M.; Landowski, J.
Psychiatria Polska 40(5): 995-1007
2006
ISSN/ISBN: 0033-2674 PMID: 17217241 Document Number: 599102
Introduction of a new group of antipsychotic drugs, called atypical because of the proprieties differing them from classical neuroleptics, gave hope for the beginning of a new era in treatment of psychoses, including schizophrenia. Different mechanisms of action not only resulted in a broader spectrum of action and high efficacy but also in a relative lack of extrapiramidal symptoms. However, atypical neuroleptics are not totally free from adverse effects. Symptoms such as sedation, metabolic changes and weight gain, often very quick and severe - present also in the case of classical drugs, but put to the background by extrapiramidal symptoms--have become prominent. Weight gain is important both from the clinical and subjective point of view--as associated with serious somatic consequences and as a source of enormous mental distress. These problems are addressed in this review, with the focus on weight gain associated with the use of specific atypical neuroleptics.